Sectors
OKUR
OnKure Therapeutics, Inc.
3.61
2 x 3.02
2 x 5.32
bid
ask
-
0.18
4.75%
10:29 AM
timesize
| Ytd | 24.48% | |
| 1y | 31.27% |
3.61
day range
3.90
2.23
52 week range
5.38
| Open | 3.80 | Prev Close | 3.79 | Low | 3.61 | High | 3.90 | Mkt Cap | 145.83M |
| Vol | 12.45K | Avg Vol | 293.99K | EPS | -3.03 | P/E | N/A | Forward P/E | -2.64 |
| Beta | 0.29 | Short Ratio | 19.81 | Inst. Own | 53.88% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 4.16 | 200-d Avg | 3.65 | 1yr Est | 34.75 |
OKUR News
benzinga.com
Oppenheimer Reiterates Outperform on OnKure Therapeutics, Lowers Price Target to $14
Oppenheimer analyst Leland Gershell reiterates OnKure Therapeutics (NASDAQ:OKUR) with a Outperfor
benzinga.com
CORRECTION: OnKure Therapeutics Q2 EPS $(0.31) Beats $(0.54) Estimate
OnKure Therapeutics (NASDAQ:OKUR) reported quarterly losses of $(0.31) per share which beat the anal
benzinga.com
HC Wainwright & Co. Maintains Buy on OnKure Therapeutics, Lowers Price Target to $21
HC Wainwright & Co. analyst Robert Burns maintains OnKure Therapeutics (NASDAQ:OKUR) with a B
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Catheter Precision (AMEX:VTAK) shares rose 78.2% to $1.55 during Monday's after-market
benzinga.com
OnKure Therapeutics Q1 EPS $(1.11) Misses $(0.64) Estimate
OnKure Therapeutics (NASDAQ:OKUR) reported quarterly losses of $(1.11) per share which missed the an
benzinga.com
OnKure Therapeutics Enters Into Securities Purchase Agreement For Private Placement Raising Gross Pr
-- Financing led by Access Biotechnology with participation from new and existing investors-- Financ
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
Micron To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Monday
Top analysts updated ratings for MU, EPAM, WLTH, OKUR, BLDR, DMRC, JBIO, CRCL. See changes and ratin
benzinga.com
Gilead Sciences To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday